Candida albicans: In vitro Inhibition of Morphological Transition by Analgesic Compounds

Autori

  • Marwan S. M Al-Nimer Professor of Pharmacology
  • Shama Mohamed Jawad Saadaldin

Parole chiave:

C. albicans, morphological transition, analgesics

Abstract

This study aimed to investigate, in vitro, the effect of some analgesic compounds, which inhibit the activity of cyclooxygenase isoenzymes, on the morphological transition of Candida albicans from unicellular budding yeast to a filamentous form. C. albicans ATCC 10231 cultured in Sabouraud’s dextrose broth supplemented with 20% human serum for 72 h at 30 °C in the presence or absence of tramadol of HCl, ketorlac tromethamine, piroxicam and acetaminophen at concentrations 6.25–200 µg/mL. The morphological transition of C. albicans was assessed microscopically in terms of budding and hyphae formation, daily for four consecutive days. The results showed that neither tramadol HCl nor acetaminophen produced significant inhibitory effects on the morphological transition of C. albicans. Ketorlac tromethamine exerted inconsistent effect on the growth of fungus cells. The inhibitory effect of piroxicam was observed at concentrations 50–100 µg/mL and sustained for four days. The authors conclude that nonselective COX enzyme inhibitors play a role in the morphological transition of C. albicans. Keywords: C. albicans, morphological transition, analgesics

Dowloads

Pubblicato

2013-12-12

Fascicolo

V. 3 N. 3 (2013)

Sezione

Research Articles

Licenza

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.